Bridgepoint Group (LON:BPT) Trading Up 0.9% – Still a Buy?

Bridgepoint Group plc (LON:BPTGet Free Report) shares rose 0.9% during mid-day trading on Wednesday . The company traded as high as GBX 346.60 ($4.39) and last traded at GBX 342 ($4.34). Approximately 115,054 shares traded hands during mid-day trading, a decline of 84% from the average daily volume of 723,706 shares. The stock had previously closed at GBX 339 ($4.30).

Analyst Upgrades and Downgrades

Separately, JPMorgan Chase & Co. raised shares of Bridgepoint Group to an “overweight” rating and lifted their price objective for the stock from GBX 259 ($3.28) to GBX 358 ($4.54) in a research note on Tuesday, August 13th.

Read Our Latest Research Report on Bridgepoint Group

Bridgepoint Group Price Performance

The company has a current ratio of 4.98, a quick ratio of 3.60 and a debt-to-equity ratio of 14.55. The company has a market capitalization of £2.81 billion, a PE ratio of 4,275.00, a price-to-earnings-growth ratio of 0.61 and a beta of 1.72. The stock’s 50-day moving average is GBX 332.22 and its two-hundred day moving average is GBX 286.21.

Bridgepoint Group Company Profile

(Get Free Report)

Bridgepoint Group plc is a private equity and private credit firm specializing in middle market, small mid cap, small cap, growth capital, buyouts investments, syndicate debt, infrastructure, direct lending and credit opportunities in private credit investments. It prefers to invest in advanced industrials, automation, agricultural sciences, energy transition enablers, business services, financial services, professional services, testing inspection and certification, information services, consumer, digital brands, video games, wellbeing products, health care, pharma and MedTech outsourced services, pharma products, and MedTech Products sectors.

See Also

Receive News & Ratings for Bridgepoint Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bridgepoint Group and related companies with MarketBeat.com's FREE daily email newsletter.